Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.

  • Authors : Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, People's Republic of China.

  • Source: Cancer [Cancer] 2017 Oct 15; Vol. 123 (20), pp. 3986-3994. Date of Electronic Publication: 2017 Jun 22.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).

  • Source: Chinese journal of cancer [Chin J Cancer] 2017 Sep 07; Vol. 36 (1), pp. 73. Date of Electronic Publication: 2017 Sep 07.Publisher: Biomed Central Country of Publication: England NLM ID: 101498232 Publication Model: Electronic Cited Medium: Internet ISSN: 1944-446X

Record details

×
Academic Journal

Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.

  • Source: International journal of surgical pathology [Int J Surg Pathol] 2019 Dec; Vol. 27 (8), pp. 816-835. Date of Electronic Publication: 2019 Aug 16.Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.

  • Authors : Liu YQ; Department of Pathology, First Teaching Hospital, Henan Key Lab for Tumor Pathology, Zhengzhou University, Henan, China.; Li HX

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2008 Aug; Vol. 132 (8), pp. 1307-12.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

[Expression of human epidermal growth factor receptor 2 in gastroesophageal cancer with different scoring systems and its relationship with clinicopathological features].

  • Authors : Ji X; Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, China.; Liu YQ

  • Source: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2011 May; Vol. 14 (5), pp. 356-9.Publisher: Zhongshan da xue Country of Publication: China NLM ID: 101177990 Publication Model: Print Cited Medium: Print ISSN: 1671-0274 (Print)

Record details

×
Academic Journal

[Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].

  • Authors : Wang J; Department of Pathology, The First Affiliated Hospital, Zhengzhou University, Henan Key Laboratory for Tumor Pathology, Zhengzhou 450052, China.; Zhang ZZ

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2008 Aug; Vol. 30 (8), pp. 566-72.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766

Record details

×
Academic Journal

STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer.

  • Authors : Cui Y; Department of Pathology, The First Affiliated Hospital of Zhengzhou University and Basic Medical College of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.; Li YY

  • Source: Oncology reports [Oncol Rep] 2016 Jul; Vol. 36 (1), pp. 108-16. Date of Electronic Publication: 2016 May 19.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.

  • Authors : Deenen MJ; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Dec; Vol. 76 (6), pp. 1285-95. Date of Electronic Publication: 2015 Oct 23.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells.

  • Authors : Wang C; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China; New Drug Research & Development Center, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China.

  • Source: PloS one [PLoS One] 2015 Jun 23; Vol. 10 (6), pp. e0130284. Date of Electronic Publication: 2015 Jun 23 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Clinical significance of phospholipase A2 group IIA (PLA2G2A) expression in primary resected esophageal squamous cell carcinoma.

  • Authors : Ren P; Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital and Key Laboratory of Cancer Prevention and Therapy, TianJin, China. ; Zhang JG

  • Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2013 Mar; Vol. 17 (6), pp. 752-7.Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Print ISSN: 1128-3602 (Print) Linking

Record details

×
  • 1-10 of  11 results for ""Liu YQ""